Topics tagged rct

Topic	Replies	Views	Activity
Mixed models modelling models random-effects , rct	14	2847	October 26, 2023
Summary Statistics vs Raw Data measurement time-to-event , ordinal , rct , multiple-endpoints , critical-care	9	10849	October 23, 2023
Comparing "all active dose" to placebo - do we treat "all active dose" as one group or separate groups? models design , rct , interpretation	2	1078	September 4, 2023
Guidance of analysis of longitudinal patient reported outcomes w.r.t Joint models modeling strategy longitudinal , rct , interpretation	4	1580	August 29, 2023
Effect modification in series of n-of-1 trials (repeated crossover) modeling strategy rct	2	1068	August 25, 2023
Data collected outside of guidelines/window rct	10	3380	June 13, 2023
Different results in unconstrained partial proportional odds model modeling strategy bayes , ordinal , rct	0	1293	May 22, 2023
Attrition Sensitive Randomisation design , randomization , missing-data , rct	1	1411	April 25, 2023
Randomization in a diagnostic study - necessary? design design , rct	3	1493	March 16, 2023
Appropriate model for combined data from two RCTs modeling strategy rct	10	1233	March 8, 2023
RCT with missing follow-up outcomes: ANCOVA + MI vs Mixed-Effects Modelling? strategy , missing-data , rct	50	9011	March 7, 2023
FDA "Bad Habits" drug development interpretation , rct	7	2467	March 4, 2023
Resources for handling blocked randomization in the analysis of RCTs modeling strategy rct	10	5138	February 11, 2023
Toward Guidelines for RCT Measurements.. What are the characteristics of an acceptable measurement for RCT? data analysis design , measurement , rct	0	1222	February 10, 2023
Rescue analysis for % change from baseline as an outcome in RCT modeling strategy rct	16	3531	January 16, 2023
The Clinical and Statistical Saga of Thrombolysis in Acute Ischemic Stroke measurement rct	11	2992	December 21, 2022
Information, Evidence, and Statistics for critical research appraisal education interpretation , bayes , rct , information	17	3784	November 21, 2022
Is it appropriate to present confidence intervals (CIs) for the outcome in each treatment group in the context of clinical trials? models rct	5	2038	November 2, 2022
Background to PFS endpoint survival-analysis , rct	19	8041	October 6, 2022
Quality of remdesivir trials journal club design , interpretation , rct	54	20251	October 5, 2022
Cdisc in academia measurement rct , data	1	1352	September 7, 2022
Patient-specific treatment effects in RCTs: why should one present them? modeling strategy prediction , rct	1	2568	August 13, 2022
Which to make as the primary analysis general design , rct	1	2576	July 25, 2022
Non-inferiority and choice of scale (absolute vs relative) rct	4	1877	July 23, 2022
Evidence Based Decision Making and Meta-Analysis -- An Information Theoretic Critique education interpretation , observational , rct	1	2858	June 10, 2022
Logistics of treatment effect estimation with interim analyses design design , rct , sequential	1	1611	June 1, 2022
Should adverse effects be adjusted for multiple comparisons? study interpretation rct	4	3641	May 24, 2022
Methodology: Benefit Risk Assessment when Risk and Benefit are only observed in different timing measurement drug-dev , safety , rct	5	2078	April 18, 2022
Covariate adjustment in non-inferiority trials models rct	3	2844	April 14, 2022
RCT and "Mathematical Embellishment" data analysis interpretation , design , rct	2	3660	April 5, 2022